POC HbA1C Testing Market Size, Share and Growth Outlook 2026: By Product Category (Instruments / Analyzers, Kits, Reagents, and Consumables), By Technology Type, By Testing Modality, By End User, Companies to 2034.
The global POC HbA1C Testing Market size is forecast to increase from $1.81 Billion in 2026 to $3.06 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034.
The POC HbA1C Testing market report provides detailed analysis and outlook of POC HbA1C Testing segments including By Product Category (Instruments / Analyzers, Kits, Reagents, and Consumables), By Technology Type (Immunoassay, Ion-Exchange High-Performance Liquid Chromatography (HPLC), Boronate Affinity Chromatography, Direct Enzymatic Assays), By Testing Modality (Handheld / Portable Devices, Benchtop Analyzers), By End User (Hospitals and Centralized Labs, Physician Office Laboratories (POLs), Specialty Diabetes Clinics and Centers, Homecare and Self-Testing Settings) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
POC HbA1c Testing Industry Overview
Decentralized Diabetes Management and Rapid Diagnostics Are Accelerating Adoption of POC HbA1c Testing
The Point-of-Care (POC) HbA1c Testing industry is undergoing significant transformation as healthcare systems increasingly shift toward decentralized diabetes management, rapid clinical decision-making, and patient-centered care delivery models. The growing global burden of diabetes, coupled with increasing demand for immediate diagnostic results in physician offices, pharmacies, community clinics, and remote care settings, is driving adoption of portable HbA1c testing platforms. Healthcare providers are prioritizing technologies that deliver laboratory-quality results with minimal sample volumes while enabling real-time treatment decisions and improved patient engagement. Simultaneously, advances in connectivity, digital health integration, and regulatory harmonization are strengthening the role of point-of-care HbA1c testing within broader diabetes management ecosystems.
Regulatory Simplification and Quality Standardization Are Supporting Global Market Expansion
The regulatory landscape for point-of-care HbA1c testing is evolving to facilitate broader global access to rapid diabetes monitoring technologies while maintaining quality assurance standards. International health organizations and regulatory agencies are increasingly adopting streamlined assessment frameworks to accelerate the availability of validated diagnostic solutions, particularly in resource-limited settings. Reflecting this trend, the World Health Organization announced a significant update to its prequalification framework for HbA1c point-of-care assays by eliminating standalone performance evaluations and shifting emphasis toward product dossier reviews, ISO 13485:2016 manufacturing inspections, and labeling assessments. This regulatory approach is expected to simplify market access pathways and support wider deployment of rapid diabetes monitoring technologies across global healthcare systems.
Connectivity, Decentralization, and Integrated Care Models Are Driving Technological Innovation
The POC HbA1c testing market is increasingly characterized by connectivity-enabled platforms and integrated diagnostic ecosystems designed to support decentralized care delivery. Siemens Healthineers continues to expand the clinical adoption of its Atellica® DCA Analyzer, which provides laboratory-quality HbA1c measurements within minutes from a 1 µL whole blood sample while offering secure connectivity to electronic health record systems, enabling immediate clinical intervention and streamlined workflow management. At the same time, Roche Diagnostics is strengthening its position in decentralized diagnostics following the integration of LumiraDx point-of-care technologies into its broader diagnostics portfolio. The company's continued investment in portable and automated diagnostic solutions reflects growing demand for telemedicine-enabled diabetes management and distributed healthcare delivery models. These developments highlight the industry's broader transition toward connected, rapid, and patient-centric diabetes monitoring solutions.
POC HbA1C Testing Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global POC HbA1C Testing market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad Laboratories, Inc., Danaher Corporation, Menarini Group, ARKRAY, Inc., Tosoh Corporation, EKF Diagnostics, i-SENS, Inc.. The POC HbA1C Testing market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the POC HbA1C Testing industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in POC HbA1C Testing industry include- Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad Laboratories, Inc., Danaher Corporation, Menarini Group, ARKRAY, Inc., Tosoh Corporation, EKF Diagnostics, i-SENS, Inc.. The POC HbA1C Testing market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US POC HbA1C Testing Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the POC HbA1C Testing market remains one of the strongest-performing segments in the country.
The US POC HbA1C Testing Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US POC HbA1C Testing market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across POC HbA1C Testing industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian POC HbA1C Testing markets
Canada's strong POC HbA1C Testing sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian POC HbA1C Testing market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany POC HbA1C Testing Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest POC HbA1C Testing market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of POC HbA1C Testing population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany POC HbA1C Testing industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the POC HbA1C Testing market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support POC HbA1C Testing sales through 2034
France POC HbA1C Testing companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK POC HbA1C Testing Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of POC HbA1C Testing distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China POC HbA1C Testing Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China POC HbA1C Testing market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of POC HbA1C Testing industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese POC HbA1C Testing industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India POC HbA1C Testing Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian POC HbA1C Testing market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil POC HbA1C Testing market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa POC HbA1C Testing Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
POC HbA1C Testing Market Segmentation
By Product Category
Instruments / Analyzers
Kits, Reagents, and Consumables
By Technology Type
Immunoassay
Ion-Exchange High-Performance Liquid Chromatography (HPLC)
Boronate Affinity Chromatography
Direct Enzymatic Assays
By Testing Modality
Handheld / Portable Devices
Benchtop Analyzers
By End User
Hospitals and Centralized Labs
Physician Office Laboratories (POLs)
Specialty Diabetes Clinics and Centers
Homecare and Self-Testing Settings
Leading Companies in POC HbA1C Testing Industry (2026)
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher Corporation
Menarini Group
ARKRAY, Inc.
Tosoh Corporation
EKF Diagnostics
i-SENS, Inc.
Countries Included
The POC HbA1C Testing market report provides detailed analysis and outlook of POC HbA1C Testing segments including By Product Category (Instruments / Analyzers, Kits, Reagents, and Consumables), By Technology Type (Immunoassay, Ion-Exchange High-Performance Liquid Chromatography (HPLC), Boronate Affinity Chromatography, Direct Enzymatic Assays), By Testing Modality (Handheld / Portable Devices, Benchtop Analyzers), By End User (Hospitals and Centralized Labs, Physician Office Laboratories (POLs), Specialty Diabetes Clinics and Centers, Homecare and Self-Testing Settings) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
POC HbA1c Testing Industry Overview
Decentralized Diabetes Management and Rapid Diagnostics Are Accelerating Adoption of POC HbA1c Testing
The Point-of-Care (POC) HbA1c Testing industry is undergoing significant transformation as healthcare systems increasingly shift toward decentralized diabetes management, rapid clinical decision-making, and patient-centered care delivery models. The growing global burden of diabetes, coupled with increasing demand for immediate diagnostic results in physician offices, pharmacies, community clinics, and remote care settings, is driving adoption of portable HbA1c testing platforms. Healthcare providers are prioritizing technologies that deliver laboratory-quality results with minimal sample volumes while enabling real-time treatment decisions and improved patient engagement. Simultaneously, advances in connectivity, digital health integration, and regulatory harmonization are strengthening the role of point-of-care HbA1c testing within broader diabetes management ecosystems.
Regulatory Simplification and Quality Standardization Are Supporting Global Market Expansion
The regulatory landscape for point-of-care HbA1c testing is evolving to facilitate broader global access to rapid diabetes monitoring technologies while maintaining quality assurance standards. International health organizations and regulatory agencies are increasingly adopting streamlined assessment frameworks to accelerate the availability of validated diagnostic solutions, particularly in resource-limited settings. Reflecting this trend, the World Health Organization announced a significant update to its prequalification framework for HbA1c point-of-care assays by eliminating standalone performance evaluations and shifting emphasis toward product dossier reviews, ISO 13485:2016 manufacturing inspections, and labeling assessments. This regulatory approach is expected to simplify market access pathways and support wider deployment of rapid diabetes monitoring technologies across global healthcare systems.
Connectivity, Decentralization, and Integrated Care Models Are Driving Technological Innovation
The POC HbA1c testing market is increasingly characterized by connectivity-enabled platforms and integrated diagnostic ecosystems designed to support decentralized care delivery. Siemens Healthineers continues to expand the clinical adoption of its Atellica® DCA Analyzer, which provides laboratory-quality HbA1c measurements within minutes from a 1 µL whole blood sample while offering secure connectivity to electronic health record systems, enabling immediate clinical intervention and streamlined workflow management. At the same time, Roche Diagnostics is strengthening its position in decentralized diagnostics following the integration of LumiraDx point-of-care technologies into its broader diagnostics portfolio. The company's continued investment in portable and automated diagnostic solutions reflects growing demand for telemedicine-enabled diabetes management and distributed healthcare delivery models. These developments highlight the industry's broader transition toward connected, rapid, and patient-centric diabetes monitoring solutions.
POC HbA1C Testing Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global POC HbA1C Testing market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad Laboratories, Inc., Danaher Corporation, Menarini Group, ARKRAY, Inc., Tosoh Corporation, EKF Diagnostics, i-SENS, Inc.. The POC HbA1C Testing market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the POC HbA1C Testing industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth POC HbA1C Testing Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by POC HbA1C Testing companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional POC HbA1C Testing markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in POC HbA1C Testing industry include- Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad Laboratories, Inc., Danaher Corporation, Menarini Group, ARKRAY, Inc., Tosoh Corporation, EKF Diagnostics, i-SENS, Inc.. The POC HbA1C Testing market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US POC HbA1C Testing Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the POC HbA1C Testing market remains one of the strongest-performing segments in the country.
The US POC HbA1C Testing Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US POC HbA1C Testing market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across POC HbA1C Testing industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian POC HbA1C Testing markets
Canada's strong POC HbA1C Testing sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian POC HbA1C Testing market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany POC HbA1C Testing Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest POC HbA1C Testing market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of POC HbA1C Testing population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany POC HbA1C Testing industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the POC HbA1C Testing market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support POC HbA1C Testing sales through 2034
France POC HbA1C Testing companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK POC HbA1C Testing Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of POC HbA1C Testing distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China POC HbA1C Testing Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China POC HbA1C Testing market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of POC HbA1C Testing industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese POC HbA1C Testing industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India POC HbA1C Testing Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian POC HbA1C Testing market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil POC HbA1C Testing market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa POC HbA1C Testing Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
POC HbA1C Testing Market Segmentation
By Product Category
Instruments / Analyzers
Kits, Reagents, and Consumables
By Technology Type
Immunoassay
Ion-Exchange High-Performance Liquid Chromatography (HPLC)
Boronate Affinity Chromatography
Direct Enzymatic Assays
By Testing Modality
Handheld / Portable Devices
Benchtop Analyzers
By End User
Hospitals and Centralized Labs
Physician Office Laboratories (POLs)
Specialty Diabetes Clinics and Centers
Homecare and Self-Testing Settings
Leading Companies in POC HbA1C Testing Industry (2026)
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher Corporation
Menarini Group
ARKRAY, Inc.
Tosoh Corporation
EKF Diagnostics
i-SENS, Inc.
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential POC HbA1C Testing Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the POC HbA1C Testing Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL POC HBA1C TESTING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global POC HbA1C Testing Markets in 2026
3.2. Global Historic and Forecast POC HbA1C Testing Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key POC HbA1C Testing Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential POC HbA1C Testing Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across POC HbA1C Testing Value Chain
CHAPTER 4- POC HBA1C TESTING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading POC HbA1C Testing Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- POC HBA1C TESTING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Category
Instruments / Analyzers
Kits, Reagents, and Consumables
By Technology Type
Immunoassay
Ion-Exchange High-Performance Liquid Chromatography (HPLC)
Boronate Affinity Chromatography
Direct Enzymatic Assays
By Testing Modality
Handheld / Portable Devices
Benchtop Analyzers
By End User
Hospitals and Centralized Labs
Physician Office Laboratories (POLs)
Specialty Diabetes Clinics and Centers
Homecare and Self-Testing Settings
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America POC HbA1C Testing Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America POC HbA1C Testing Market Trends and Growth Opportunities to 2034
7.5. North America POC HbA1C Testing Market Size Outlook by Type
7.6. North America POC HbA1C Testing Market Size Outlook by Application
7.7. North America POC HbA1C Testing Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US POC HbA1C Testing Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US POC HbA1C Testing Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada POC HbA1C Testing Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada POC HbA1C Testing Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico POC HbA1C Testing Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico POC HbA1C Testing Companies
CHAPTER 8- EUROPE POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe POC HbA1C Testing Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe POC HbA1C Testing Market Trends and Growth Opportunities to 2034
8.5. Europe POC HbA1C Testing Market Size Outlook by Type
8.6. Europe POC HbA1C Testing Market Size Outlook by Application
8.7. Europe POC HbA1C Testing Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany POC HbA1C Testing Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany POC HbA1C Testing Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France POC HbA1C Testing Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France POC HbA1C Testing Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom POC HbA1C Testing Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK POC HbA1C Testing Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain POC HbA1C Testing Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain POC HbA1C Testing Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy POC HbA1C Testing Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy POC HbA1C Testing Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe POC HbA1C Testing Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe POC HbA1C Testing Companies
CHAPTER 9- ASIA PACIFIC POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific POC HbA1C Testing Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific POC HbA1C Testing Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific POC HbA1C Testing Market Size Outlook by Type
9.6. Asia Pacific POC HbA1C Testing Market Size Outlook by Application
9.7. Asia Pacific POC HbA1C Testing Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China POC HbA1C Testing Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China POC HbA1C Testing Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan POC HbA1C Testing Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan POC HbA1C Testing Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India POC HbA1C Testing Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India POC HbA1C Testing Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea POC HbA1C Testing Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea POC HbA1C Testing Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia POC HbA1C Testing Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia POC HbA1C Testing Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia POC HbA1C Testing Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia POC HbA1C Testing Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America POC HbA1C Testing Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America POC HbA1C Testing Market Trends and Growth Opportunities to 2034
10.5. South and Central America POC HbA1C Testing Market Size Outlook by Type
10.6. South and Central America POC HbA1C Testing Market Size Outlook by Application
10.7. South and Central America POC HbA1C Testing Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil POC HbA1C Testing Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil POC HbA1C Testing Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina POC HbA1C Testing Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina POC HbA1C Testing Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America POC HbA1C Testing Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America POC HbA1C Testing Companies
CHAPTER 11- MIDDLE EAST AND AFRICA POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa POC HbA1C Testing Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa POC HbA1C Testing Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa POC HbA1C Testing Market Size Outlook by Type
11.6. Middle East and Africa POC HbA1C Testing Market Size Outlook by Application
11.7. Middle East and Africa POC HbA1C Testing Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia POC HbA1C Testing Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia POC HbA1C Testing Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE POC HbA1C Testing Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE POC HbA1C Testing Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa POC HbA1C Testing Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa POC HbA1C Testing Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in POC HbA1C Testing Industry
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher Corporation
Menarini Group
ARKRAY, Inc.
Tosoh Corporation
EKF Diagnostics
i-SENS, Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential POC HbA1C Testing Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the POC HbA1C Testing Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL POC HBA1C TESTING MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global POC HbA1C Testing Markets in 2026
3.2. Global Historic and Forecast POC HbA1C Testing Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key POC HbA1C Testing Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential POC HbA1C Testing Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across POC HbA1C Testing Value Chain
CHAPTER 4- POC HBA1C TESTING MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading POC HbA1C Testing Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- POC HBA1C TESTING MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Category
Instruments / Analyzers
Kits, Reagents, and Consumables
By Technology Type
Immunoassay
Ion-Exchange High-Performance Liquid Chromatography (HPLC)
Boronate Affinity Chromatography
Direct Enzymatic Assays
By Testing Modality
Handheld / Portable Devices
Benchtop Analyzers
By End User
Hospitals and Centralized Labs
Physician Office Laboratories (POLs)
Specialty Diabetes Clinics and Centers
Homecare and Self-Testing Settings
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America POC HbA1C Testing Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America POC HbA1C Testing Market Trends and Growth Opportunities to 2034
7.5. North America POC HbA1C Testing Market Size Outlook by Type
7.6. North America POC HbA1C Testing Market Size Outlook by Application
7.7. North America POC HbA1C Testing Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US POC HbA1C Testing Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US POC HbA1C Testing Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada POC HbA1C Testing Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada POC HbA1C Testing Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico POC HbA1C Testing Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico POC HbA1C Testing Companies
CHAPTER 8- EUROPE POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe POC HbA1C Testing Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe POC HbA1C Testing Market Trends and Growth Opportunities to 2034
8.5. Europe POC HbA1C Testing Market Size Outlook by Type
8.6. Europe POC HbA1C Testing Market Size Outlook by Application
8.7. Europe POC HbA1C Testing Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany POC HbA1C Testing Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany POC HbA1C Testing Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France POC HbA1C Testing Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France POC HbA1C Testing Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom POC HbA1C Testing Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK POC HbA1C Testing Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain POC HbA1C Testing Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain POC HbA1C Testing Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy POC HbA1C Testing Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy POC HbA1C Testing Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe POC HbA1C Testing Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe POC HbA1C Testing Companies
CHAPTER 9- ASIA PACIFIC POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific POC HbA1C Testing Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific POC HbA1C Testing Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific POC HbA1C Testing Market Size Outlook by Type
9.6. Asia Pacific POC HbA1C Testing Market Size Outlook by Application
9.7. Asia Pacific POC HbA1C Testing Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China POC HbA1C Testing Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China POC HbA1C Testing Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan POC HbA1C Testing Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan POC HbA1C Testing Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India POC HbA1C Testing Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India POC HbA1C Testing Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea POC HbA1C Testing Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea POC HbA1C Testing Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia POC HbA1C Testing Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia POC HbA1C Testing Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia POC HbA1C Testing Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia POC HbA1C Testing Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America POC HbA1C Testing Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America POC HbA1C Testing Market Trends and Growth Opportunities to 2034
10.5. South and Central America POC HbA1C Testing Market Size Outlook by Type
10.6. South and Central America POC HbA1C Testing Market Size Outlook by Application
10.7. South and Central America POC HbA1C Testing Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil POC HbA1C Testing Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil POC HbA1C Testing Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina POC HbA1C Testing Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina POC HbA1C Testing Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America POC HbA1C Testing Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America POC HbA1C Testing Companies
CHAPTER 11- MIDDLE EAST AND AFRICA POC HBA1C TESTING MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa POC HbA1C Testing Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa POC HbA1C Testing Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa POC HbA1C Testing Market Size Outlook by Type
11.6. Middle East and Africa POC HbA1C Testing Market Size Outlook by Application
11.7. Middle East and Africa POC HbA1C Testing Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia POC HbA1C Testing Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia POC HbA1C Testing Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE POC HbA1C Testing Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE POC HbA1C Testing Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa POC HbA1C Testing Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa POC HbA1C Testing Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in POC HbA1C Testing Industry
Siemens Healthineers AG
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Danaher Corporation
Menarini Group
ARKRAY, Inc.
Tosoh Corporation
EKF Diagnostics
i-SENS, Inc.
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
